| Marna M Crow, CNM | |
|
1027 Washington Ave, Detroit Lakes, MN 56501-3409 | |
| (218) 847-5611 | |
| (218) 847-0881 |
| Full Name | Marna M Crow |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 1027 Washington Ave, Detroit Lakes, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275573891 | NPI | - | NPPES |
| 16062 | Other | MN | NDBS # |
| 0701541 | Other | FM | MEDICA # |
| 142329 | Other | MN | UCARE # |
| 41Q41CR | Other | MN | MNBS # |
| 900601 | Other | MN | AMERICA'S PPO/ARAZ # |
| HP25731 | Other | MN | HEALTHPARTNERS # |
| MN200030 | Other | FM | LHS/BANNERHEALTH # |
| DA9031026965 | Other | MN | PREFERRED ONE # |
| 077819200 | Medicaid | MN | |
| 19736 | Medicaid | FM | |
| 0701540 | Other | MN | MEDICA # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | R069384-4 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marna M Crow, CNM 1027 Washington Ave, Detroit Lakes, MN 56501-3409 Ph: (218) 847-5611 | Marna M Crow, CNM 1027 Washington Ave, Detroit Lakes, MN 56501-3409 Ph: (218) 847-5611 |
News Archive
A recent study determined glucocorticoid-induced osteoporosis (OP) is now treatable with Teriparatide, a synthetic form of the human parathyroid hormone. Researchers found patients with glucocorticoid-induced OP who were treated with teriparatide for 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of treatments for the most challenging infectious diseases, today announced that its abstract titled "ACH-1625 Demonstrates Sustained Viral Suppression in Presence of Uncommon Drug Resistant HCV Variants: Pharmacokinetic, Pharmacodynamic and Clinical Virology Analysis of Phase I Study" has been accepted as a late breaking poster presentation at the 61st Annual Meeting of the American Association for the Study of Liver Disease The Liver Meeting 2010 being held October 29-November 2, 2010 in Boston.
Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.
In a paper published online this week in Science Express (the online version of Science magazine), researchers report that early clinical trials for two compounds, MDV3100 and RD162, show initial promise for patients suffering from an advanced metastatic form of the disease known as castration-resistant prostate cancer.
An antimicrobial agent found in common household soaps, shampoos and toothpastes may be finding its way inside human noses where it promotes the colonization of Staphylococcus aureus bacteria and could predispose some people to infection.
› Verified 2 days ago
Hope L Adams, APRN,CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1027 Washington Ave, Detroit Lakes, MN 56501 Phone: 218-847-5611 |